new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Revalesio Corporation patents

Recent patent applications related to Revalesio Corporation. Revalesio Corporation is listed as an Agent/Assignee. Note: Revalesio Corporation may have other listings under different names/spellings. We're not affiliated with Revalesio Corporation, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "R" | Revalesio Corporation-related inventors




Date Revalesio Corporation patents (updated weekly) - BOOKMARK this page
09/22/16Compositions and methods for enhancing physiological performance and recovery time
02/11/16Methods and trapping and size resolution of nanoparticles and nanobubbles
02/04/16Mixing device for creating an output mixture by mixing a first material and a second material
01/21/16Compositions and methods for treating insulin resistance and diabetes mellitus
01/14/16Compositions and methods for treating digestive disorders
07/23/15Compositions and methods for enhancing neuronal phosphorylation homeostasis, and modulating dysfunctional exocytosis and neurotransmitter release
02/19/15Methods of wound care and treatment
02/19/15Compositions and methods for upregulating hippocampal plasticity and hippocampus-dependent learning and memory
02/19/15Compositions and methods for treating insulin resistance and diabetes mellitus
01/22/15Methods of therapeutic treatment of eyes
09/11/14Methods of wound care and treatment
06/12/14Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
04/10/14Methods of therapeutic treatment of eyes
03/27/14Methods of wound care and treatment
10/03/13Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
09/26/13Mixing device for creating an output mixture by mixing a first material and a second material
04/18/13Diffuser/emulsifier for aquaculture applications
10/18/12Compositions and methods for inhibiting and/or modulating effector t-cells involved in inflammatory neurodegenerative disease
05/17/12Methods and compositions for protecting against neurotoxicity of a neurotoxic agent, and improving motor coordination associated with a neurodegenerative condition or disease
05/10/12Compositions and methods for treating asthma and other lung disorders
02/16/12Compositions and methods for treating cardiovascular disease
02/16/12Compositions and methods for enhancing physiological performance and recovery time
02/16/12Compositions and methods for treatment of taupathy
02/09/12Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
01/19/12Diffuser/emulsifier for aquaculture applications
05/05/11Mixing device
04/07/11Methods of wound care and treatment
03/31/11Diffuser/emulsifier
01/13/11System and therapeutic application of dissolved oxygen
12/16/10Compositions and methods for treating inflammation
12/09/10Compositions and methods for treatment of neurodegenerative diseases
12/09/10Compositions and methods for treating insulin resistance and diabetes mellitus
12/09/10Bacteriostatic or bacteriocidal compositions and methods
12/09/10Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
12/02/10Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
12/02/10Compositions and methods for treating cystic fibrosis
12/02/10Compositions and methods for treating asthma and other lung disorders
11/25/10Methods of therapeutic treatment of eyes
04/22/10Compositions and methods for treating matrix metalloproteinase 9 (mmp9)-mediated conditions
04/22/10Compositions and methods for treating thymic stromal lymphopoietin (tslp)-mediated conditions
02/18/10Mixing device
02/04/10Compositions and methods for treating multiple sclerosis
02/04/10Methods of therapeutic treatment of eyes
02/04/10Compositions and methods for treating inflammation
02/04/10Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
01/28/10Methods of wound care and treatment
01/21/10Compositions and methods for treating multiple sclerosis
01/14/10Compositions and methods for treating asthma and other lung disorders
01/14/10Bacteriostatic or bacteriocidal compositions and methods
01/07/10Compositions and methods for treating digestive disorders
01/07/10Compositions and methods for treating cystic fibrosis
11/05/09Compositions and methods for treating inflammation
11/05/09Compositions and methods for treating asthma and other lung disorders
10/22/09Bacteriostatic or bacteriocidal compositions and methods
10/01/09Compositions and methods for treating cystic fibrosis
09/10/09Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Revalesio Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Revalesio Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';